Navigation Links
ADVENTRX Pharmaceuticals Announces Closing of Financing
Date:7/6/2009

idend and other payments due its 5% Series B convertible preferred stock (or to the holders thereof), which may be a breach of its certificate of incorporation or other contractual obligations and expose ADVENTRX to corresponding liability; the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to submit an NDA for ANX-530, to fund operations, including pre-launch activities, during the FDA review period, if an NDA is submitted, or to conduct launch activities, should an NDA for ANX-530 be approved; the risk that ADVENTRX will be unable to raise sufficient additional capital on a timely basis to continue as a going concern; the risk that ADVENTRX will seek protection under the provisions of the U.S. Bankruptcy Code; the risk that ADVENTRX will reassess the results of the ANX-530 bioequivalence study and determine to conduct additional bioequivalence studies of ANX-530, including in humans; the potential for regulatory authorities to require additional preclinical work and/or clinical activities to support regulatory filings, including prior to the submission or the approval of an NDA for ANX-530, which activities may increase the cost and timeline to NDA submission or approval; the risk the FDA will determine that ANX-530 and Navelbine(R) are not bioequivalent, including as a result of performing pharmacokinetic equivalence analysis based on a patient population other than the population on which ADVENTRX based its analysis; difficulties or delays in manufacturing, obtaining regulatory approval for and marketing ANX-530, including validating commercial manufacturing processes and manufacturers, as well as suppliers; the risk that ADVENTRX will trigger a "maintenance failure" under that certain Rights Agreement, dated July 27, 2005, as amended, and be required to pay liquidated damages, including as a result of losing its eligibility to use Form S-3 if its common stock is delisted from the NYSE Amex; and other risks and uncerta
'/>"/>
SOURCE ADVENTRX Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. ADVENTRX Pharmaceuticals to Present at the 18th Annual CIBC Healthcare Conference
2. ADVENTRX Pharmaceuticals to Present at the 13th Annual BIO-Europe Partnering Conference
3. ADVENTRX Pharmaceuticals to Present at the 2007 RBC Capital Markets Healthcare Conference
4. ADVENTRX Pharmaceuticals to Present at The 10th Annual BIO CEO & Investor Conference
5. ADVENTRX Pharmaceuticals to Report First Quarter 2008 Results
6. ADVENTRX Pharmaceuticals Reports Second Quarter 2008 Financial Results and Business Update
7. ADVENTRX Pharmaceuticals to Report Third Quarter 2008 Results
8. ADVENTRX Grants Exclusive Rights to ANX-514 in South Korea
9. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
10. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
11. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/1/2014)... October 01, 2014 Today marks the ... Dental Art Institute in Oxnard and Woodland Hills, Calif., ... full mouth rehabilitation training. , “Speaking to this group ... transformative procedures to get the help and care they ... involve repairing previous dental work, providing cosmetic dentistry, correcting ...
(Date:10/1/2014)... October 01, 2014 After undergoing a ... chamber of commerce to join, Living Well Assisted Living ... Commerce in Marin County, the home of its headquarters. ... the moment, and the thought of adding one more ... to keep looking for the right chamber to join ...
(Date:10/1/2014)... is safer and more effective than intermediate-acting insulin ... new research published in the BMJ . ... doses of both long- and intermediate-acting insulin, ranking ... patients with Type 1 diabetes, we found that ... it came to controlling blood sugar, preventing weight ...
(Date:10/1/2014)... 01, 2014 The Oliver Law ... new Other-Sonic Ultrasound Gel lawsuit web page ... the litigation surrounding the 2011 Pseudomonas aeruginosa / ... Royal Oak, Michigan, which was ultimately traced to ... representing William Beaumont patients who allegedly became ill ...
(Date:10/1/2014)... 01, 2014 Industrial freezers ... out of 5, which indicates moderate negotiating power ... beverage manufacturers, food service businesses, healthcare facilities and ... these users' diversity, demand for industrial freezers increases ... production, consumer spending and nonresidential construction have corresponded ...
Breaking Medicine News(10 mins):Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 2Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 3Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 4Health News:Internationally Respected Oxnard Dentist Concludes All-on-4™ Dental Implants Training Today 5Health News:Living Well Joins San Rafael Chamber of Commerce 2Health News:Living Well Joins San Rafael Chamber of Commerce 3Health News:Long-acting insulin is safer, more effective for patients with Type 1 diabetes 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 2Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 3Health News:Other-Sonic Ultrasound Gel Lawsuit Page Launched by The Oliver Law Group P.C. To Provide Information On Pseudomonas Outbreak Linked to Recalled Ultrasound Gel 4Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 2Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 3Health News:Industrial Freezers Procurement Category Market Research Report Now Available from IBISWorld 4
... ST. PAUL, Minn., July 28 Higher summertime levels of ... as well as other air pollutants may cause anyone who ... breath, wheezing and coughing, and may also trigger asthma attacks ... for reporting daily air quality, cities in California, including but ...
... , NEW ORLEANS, July 28 Due ... problems across the United States, Louisiana optometrists are devoting appointments ... six to 12 months of age through InfantSEE(R). InfantSEE(R), a ... Foundation in partnership with The Vision Care Institute(TM), LLC a ...
... Tenn., July 28 Health Connect Partners, Inc. ( www.hlthcp.com ... title sponsor of its 2009 Fall Hospital Pharmacy Conference. , ... to 200 directors of pharmacy from some of the largest hospitals ... led by healthcare industry experts, the Hospital Pharmacy Conference will offer ...
... , NEW YORK, July 28 The National Center on ... C. Tuggle has been elected to its board of directors. , ... , Tuggle is senior vice president of Global Public ... in 1989 and has held a variety of positions in the U.S. ...
... , ROCHESTER, N.Y., July 28 VirtualScopics, Inc. ... for clinical trials, today announced that on Wednesday, August 12, 2009 ... will host a conference call to discuss these results on Thursday, ... VirtualScopics, President and Chief Executive Officer, Jeff Markin, and ...
... , , , ... has announced the launch of an Active Duty Military Tuition Grant ... as well as for drilling members of the National Guard and ... Organizational Leadership. , , The Active Duty Military ...
Cached Medicine News:Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 2Health News:Bad Air Day Alert: Outdoor Air Pollutants at High Level 3Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 2Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 3Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 4Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 5Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 6Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 7Health News:Louisiana Optometrists Partner With Sens. Landrieu and Vitter, U.S. House Leaders in Improving Infant Eye and Vision Care 8Health News:Cardinal Health Announced as Title Sponsor of the Health Connect Partners' 2009 Fall Hospital Pharmacy Conference 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 2Health News:Clyde C. Tuggle, Senior Vice President at The Coca-Cola Company, Elected to CASA* Board 3Health News:VirtualScopics Schedules Second Quarter 2009 Earnings Announcement 2Health News:University of the Rockies Introduces Military Tuition Grant 2
(Date:10/1/2014)... 1, 2014 Sophia Genetics, ... domaine de l,analyse des données issues du SNG ... de diagnostic in vitro (IVD) du gène CFTR ... la mucoviscidose dans un seul essai SGN. La ... les types de variantes par l,intermédiaire d,un seul ...
(Date:9/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ), today announced ... Executive Officer, will preside over the NASDAQ Stock Market ... of Breast Cancer Awareness Month. In his remarks, Mr. ... important benefits of Hologic,s 3D Mammography technology, the only ... to traditional mammography. This is the ninth ...
(Date:9/30/2014)... , Sept. 30, 2014 Arbor Pharmaceuticals, ... Summary Global Markets Direct,s, ,Arbor Pharmaceuticals, LLC. ... overview of the Arbor Pharmaceuticals, LLC.,s pharmaceutical research ... information on the current therapeutic developmental pipeline of ... various stages, therapeutics assessment by drug target, mechanism ...
Breaking Medicine Technology:Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 2Sophia Genetics lance une analyse complète du gène CFTR dans un essai clinique SGN 3Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 2Hologic to Kick Off National Breast Cancer Awareness Month at the October 1 NASDAQ Stock Market Opening Bell Ceremony 3Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 2Arbor Pharmaceuticals, LLC. - Product Pipeline Review - 2014 3
... 2011 Volcano Corporation (NASDAQ: VOLC ), ... and therapy guidance tools designed to enhance the treatment ... it will be participating in the Tenth Annual JMP ... The presentation by John Dahldorf, chief financial officer, will ...
... May 2, 2011 SeraCare Life Sciences announced today ... of the National Institutes of Health has awarded a ... expired on April 30, 2011. Under this contract, SeraCare, ... proper collection, processing and storage for biorepository collections. SeraCare ...
Cached Medicine Technology:SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research 2SeraCare Life Sciences Announces Renewal of National Institutes of Health Contract to Support Research 3
... MD Coder is simply more ... is a handheld solution for ... for both individual physicians and ... v6.0 now comes in three ...
The focus of HandEchart Professional is to offer a practical and basic electronic patient record keeping system that anyone can learn in minutes....
... 3000 is a computerized medical ... 3000 encompasses a wide array ... criteria sets and decision tree ... clinicians, medical educators, nurses and ...
... an advanced medical calculator and ... Dosing and Critical Care for ... logical complement to other PDA ... Daviss Drug Guide, PDR or ...
Medicine Products: